Agenus Inc (NASDAQ: AGEN) Up 3.54%: This Is What Analysts Now Expect

Agenus Inc (NASDAQ:AGEN) shares, rose in value, with the stock price up by 3.54% to the previous day’s close as strong demand from buyers drove the stock to $0.53.

Actively observing the price movement in the last trading, the stock closed the session at $0.51. The value of beta (5-year monthly) was 1.27. Referring to stock’s 52-week performance, its high was $2.13, and the low was $0.49. On the whole, AGEN has fluctuated by -22.28% over the past month.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

With the market capitalization of Agenus Inc currently standing at about $222.07 million, investors are eagerly awaiting this quarter’s results, scheduled for Mar 14, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.15, which is expected to increase to $0.1 for fiscal year -$0.32 and then to about -$0.69 by fiscal year 2025. Data indicates that the EPS growth is expected to be 53.60% in 2025, while the next year’s EPS growth is forecast to be -115.60%.

Analysts have estimated the company’s revenue for the quarter at $41.46 million, with a low estimate of $34 million and a high estimate of $48.05 million. According to the average forecast, sales growth in current quarter could jump up 81.00%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $191.52 million, representing an increase of 22.50% from the revenues reported in the last year’s results.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that AGEN’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.

The stock’s technical analysis shows that the PEG ratio is about 0, with the price of AGEN currently trading nearly -11.43% and -18.43% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.07, while the 7-day volatility ratio is showing 7.85% which for the 30-day chart, stands at 8.91%. Furthermore, Agenus Inc (AGEN)’s beta value is 1.29, and its average true range (ATR) is 0.06.

A comparison of Agenus Inc (AGEN) with its peers suggests the former has fared considerably weaker in the market. AGEN showed an intraday change of 3.54% in last session, and over the past year, it shrunk by -64.46%%.

Data on historical trading for Agenus Inc (NASDAQ:AGEN) indicates that the trading volumes over the past 10 days have averaged 6.37 million and over the past 3 months, they’ve averaged 10.13 million. According to company’s latest data on outstanding shares, there are 418.92 million shares outstanding.

Nearly 5.41% of Agenus Inc’s shares belong to company insiders and institutional investors own 54.83% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 45.75 million shares as on Mar 15, 2024, resulting in a short ratio of 3.62. According to the data, the short interest in Agenus Inc (AGEN) stood at 10.92% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 43.2 million. The stock has fallen by -35.97% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AGEN stock heading into the next quarter.